Trial Profile
A Single Center, Double-blinded, ,Placebo-controlled Phase I Clinical Trial in Healthy Volunteer to Evaluate Tolerance and Pharmacokinetics of Meplazumab of Injection
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Apr 2021
Price :
$35
*
At a glance
- Drugs Meplazumab (Primary)
- Indications COVID 2019 infections; Malaria
- Focus Adverse reactions
- 07 Apr 2021 Status changed from recruiting to completed.
- 05 May 2020 New trial record